Ashok Leyland Q4FY2016: Operating results in line with estimates
Ashok Leyland Q4FY2016 results: Operating results in line with estimates; dimunition in value of investments dents profits severely
Ashok Leyland Ltd has announced the following Q4 & FY16 results for the quarter & year ended March 31, 2016:
Standalone
For the Quarter ended March 31, 2016
The Company has posted a net profit after tax of Rs77.02 crore Vs Rs229.97 crore.
Total Income has increased to Rs5987.23 crore Vs Rs4542.95 crore.
Cipla cracks on weak quarterly results
Shares of Cipla cracked 6% to Rs465 on weak results on account of one-offs; maintain Hold with unchanged PT of Rs581
Result synopsis: Sales for the quarter grew by 5.6% to Rs3, 266.5 crores; operating profit declined by 57% to Rs219 crore; operating profit margin (OPM) declined by 971BPS to 6.7% and profit for the quarter declined by 69% to Rs81 crore.
The domestic sales grew by 15.9% to Rs1, 258 crore; export formulation grew by 3% to Rs1, 744 crore and active pharmaceutical ingredient (API) exports remained flat at Rs204 crore.
Tech Mahindra rallies as Q4FY16 profit beats street
Shares of Tech Mahindra rallied 11% to Rs532 on NSE post Q4FY16 results led by in line performance, profit beat led by forex gain and lower tax rate.
Revenues for the quarter was up by 1.3% QoQ on CC term and 0.8% on a reported basis to $1,022.6 mn (in line with expectations).
The growth was led by enterprise side of business especially BFSI vertical, which was higher by 8.7% qoq on CC basis, while Telecom growth remain muted on sequential basis.
Bajaj Auto Q4FY2016 inline; lower other income lead to Net profit miss
Bajaj Auto Q4FY2016 results: Operationally inline; lower other income lead to Net profit miss
Bajaj Auto Ltd has announced the following Q4 & FY16 results for the quarter & year ended March 31, 2016:
Standalone
For the Quarter ended March 31, 2016 (YoY)
Net Profit rose by 29.18% to Rs803.06 crore Vs Rs621.62 crore.
Total Income increased by 13.11% to Rs5535.56 crore Vs Rs4893.61 crore.
Cadila gets USFDA nod for Variconazole tablets
Cadila gets USFDA nod for Variconazole tablets; an anti-fungal drug; to be manufactured at Baddi facility – Sentimentally positive for Cadila.
Read our more services below:
CapitalStars Financial Research Financial Advisory Services
No comments:
Post a Comment